7th Sep 2011 07:00
7 September 2011
Allergy Therapeutics plc
("Allergy Therapeutics" or "the Company")
Notice of Results
Allergy Therapeutics plc (AIM: "AGY" or the "Company"), the fully integrated specialty pharmaceutical company specializing in allergy vaccines, will announce its Preliminary Results for the year ended 30 June 2011 on Monday 19 September 2011.
-Ends-
For further information
Financial Dynamics | +44 (0) 207 831 3113 |
Jonathan Birt/ Susan Quigley |
About Allergy Therapeutics
Allergy Therapeutics is a speciality pharmaceutical company focused on allergy vaccination. It has a growing business achieving sales of allergy vaccines in the prior financial year of £41 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets.
Related Shares:
Allergy Thera.